TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Kris Ruanjaikaen, Ph.D.
Senior Engineer, ASO Process Development and Manufacturing at Biogen

Profile

Kris Ruanjaikaen is a Senior Engineer with the ASO Development and Manufacturing group at Biogen in Boston, USA. The group is responsible for development and manufacturing of oligonucleotide pipeline and functions at the interface of various teams such as Research, Clinical/Preclinical, Regulatory, Supply Chain, Quality, etc. Kris leads and develops early-phase oligonucleotide programs targeting neurological diseases. He helped the teams streamline the CMC development activities and accelerate timeline to the clinic. Prior to Biogen, Kris was a purification scientist in the Manufacturing Science group at Novartis where he worked closely with Manufacturing to support Phase III and commercialization of vaccines. Kris holds a PhD in Chemical Engineering from the Pennsylvania State University.

Kris Ruanjaikaen, Ph.D.'s Network

Agenda Sessions

  • Accelerating Early Phase Development of Oligonucleotides

    , 10:30